- In May 2024, Edwards Lifesciences has launched the SAPIEN 3 Ultra RESILIA valve in Europe, featuring the company’s innovative RESILIA tissue technology to improve valve durability. This launch strengthens Edwards Lifesciences' competitive edge by offering a more durable solution in the growing transcatheter heart valve market
- In January 2024, Venus Medtech announced that its innovative transcatheter pulmonic valve replacement (TPVR) system, VenusP-Valve, has received approval from Health Canada. This approval enhances the company’s market presence and opens up new growth opportunities in the Canadian healthcare market
- In February 2023, Medtronic has reintroduced its Harmony™ Transcatheter Pulmonary Valve (TPV) System, offering a minimally invasive option for congenital heart disease patients with native or repaired right ventricular outflow tract (RVOT). This relaunch is expected to enhance the company's position in the growing TPVR market by providing a more effective treatment alternative
